AuntMinnie.com staff writersMRIIMRIS’ new MRI system secures U.S. FDA clearanceIMRISThe system provides a path for IMRIS Operating Suites to upgrade MRI scanners.August 13, 2025UltrasoundFDA clears Sonic Incytes’ POCUS deviceSonic Incytes Medical has received U.S. FDA clearance for its point-of-care ultrasound (POCUS) elastography device, Velacur One.August 13, 2025Nuclear MedicineInternational Isotopes posts Q2 revenue increaseThe increase was partially due to the remedying of the global shortage of cobalt-57 isotope.August 13, 2025PACS/VNAMedDream launches latest version of DICOM viewerVersion 8.7 introduces enhanced privacy tools, performance upgrades, and new features to optimize medical imaging workflows.August 13, 2025PACS/VNARhapsody releases new DICOM systemThe company is showcasing the system and its full digital health enablement platform at the MedInformatix Summit.August 13, 2025CTNVIDIA partners with 12 global institutions on pancreatic CT datasetNVIDIA has collaborated with 12 global institutions to create a comprehensive pancreatic CT dataset, with the aim of improving early-detection rates for pancreatic cancer.August 12, 2025Molecular ImagingCatalyst MedTech launches nuclear medicine tech training programThe Catalyst MedTech Nuclear Medicine Technologist Program will operate in conjunction with Westmoreland County Community College.August 12, 2025CTMARS Bioimaging advances Series A round for color CT imaging systemMARS Bioimaging is advancing the final phase of its Series A investment round.August 12, 2025MRIPolarean submits trial protocol to FDA for MRI contrast agentPolarean has submitted a clinical trial protocol to the U.S. FDA for an expanded indication for its lung MRI Xenoview contrast agent.August 12, 2025Nuclear MedicineDOE, state of Missouri, University of Missouri to collaborateFunding raised in the partnership will support a new radioisotope development center at Discovery Ridge in Columbia.August 11, 2025Previous PagePage 119 of 306Next PageTop StoriesMRIMRI, PET reveal distinct brain changes in loneliness and social isolationPrior studies frequently have used the terms interchangeably and applied measures designed for one construct when investigating the other.MRIPodcast: Hospital accreditation isn’t a safety net for MRIAISIIM-CAIMI program chairs talk medical imaging AI's evolutionCTLDCT predicts vertebral fracture risk in heavy smokersSponsor ContentFree Webinar: Agentic AI in Radiology
![Images depict axial MRI scans in a 50-year-old premenopausal female patient with biopsy-proven 12-mm invasive lobular cancer in the lower outer quadrant of the left breast. Upper images are subtracted dynamic contrast-enhanced (DCE) MRI scans from the first and second postcontrast acquisitions. Lower images are ultrafast MRI scans obtained within 24 hours after the DCE study (four consecutive subtracted dynamic frames from time points [T] 6–9). There is marked background parenchymal enhancement (BPE) on the DCE MRI scans. Thus, the known cancer (arrow) is barely visible; it exhibits only slightly stronger enhancement than the normal fibroglandular tissue, which results in low conspicuity. At ultrafast MRI there is less BPE, and still the cancer is barely visible because it starts to enhance simultaneously with the BPE. The conspicuity of the cancer is even reduced compared with the DCE series. Both of the readers missed this cancer on both the DCE and ultrafast MRI scans.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2025/05/2025-05-06-rsna-ultrafast-dce-mri-breast.Gzvq76udFr.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
